{
    "2019-05-09": [
        [
            {
                "time": "",
                "original_text": "白云山(00874)：广药集团被纳入国企改革‘双百企业’名单",
                "features": {
                    "keywords": [
                        "白云山",
                        "广药集团",
                        "国企改革",
                        "双百企业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "国企改革"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山(00874.HK)：广药集团获新增纳入国企改革‘双百企业’名单",
                "features": {
                    "keywords": [
                        "白云山",
                        "广药集团",
                        "国企改革",
                        "双百企业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "国企改革"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山：控股股东被纳入‘双百企业’名单",
                "features": {
                    "keywords": [
                        "白云山",
                        "控股股东",
                        "双百企业"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "国企改革"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "ED市场群雄逐鹿，‘伟哥之王’2019年或将易主？",
                "features": {
                    "keywords": [
                        "ED市场",
                        "伟哥",
                        "2019年",
                        "易主"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药",
                        "市场竞争"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "白云山（600332.SH）2019年一季报点评：春季发货助力利润高增长，维持‘买入’评级",
                "features": {
                    "keywords": [
                        "白云山",
                        "2019年一季报",
                        "利润高增长",
                        "买入评级"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药",
                        "财务表现"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}